A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Metastases
Sponsor: Genentech, Inc.